Sunteți pe pagina 1din 38

Good Manufacturing Practice

Overview of concept
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003 By: Alireza Khadem

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Objectives of the workshop


Ensure that NRA will be able to conduct adequate GMP inspections
All GMP inspectors supervising EPI vaccine manufacturers will improve their skills in conducting competent and efficient GMP inspections identify GMP experts that can participate/facilitate in international peer review audits or GMP training/follow up

Develop a plan to ease enforcement of GMP in all EPI vaccine manufacturers


training of QA managers in self inspection Follow up and monitoring of GMP audits findings
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Expected outcome at the end of the workshop


A workplan to ease enforcement of GMP in by the NRA A workplan to implement and improve GMP in all EPI vaccine manufacturers A short term and long term training development plan of GMP inspectors and QA managers Identify the best resources persons to participate in WHO GMP audits or GMP training
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Organization & method of work


10-18 November, 8.30 am -5.30 including coffee break and lunch Evaluation of knowledge before, during and after the workshop Lectures based on need assessment Mock audit in two facilities (15,16 Nov) Work plan at the end of the workshop Plenary and working group sessions

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Why GMP
Patients taking medicines have very little chance of detecting if anything is wrong If something is wrong it can be very dangerous The doctor, pharmacist and patient, all trust those who manufactured and packaged the product
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

History of GMP
1930 Lubeck BCG Vaccine

251 vaccinated 72 deaths because of tuberculosis 135 developed clinical tuberculosis 44 survived

Thorough investigations following this incident, it become very probable that batches of the vaccine were contaminated with the so-called Kiel-strain

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

History of GMP
1938 - Sulphanilamide, the elixir of death

358 poisonings 107 deaths 251 sick but survived

FDCA-1938

The "miracle drug" came into use. It was marketed as a pediatric elixir. It was a raspberry flavoured solution in a liquid industrial solvent, etheylene glycol. Generally an elixir is designated as an alcohol based product, but this particular formulation was of dietheylene glycol. Upon ingestion, ethylene glycol was metabolized to oxalic acid.
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

History of GMP
1962- Thalidomide

thousands of babies were born without arms or legs


Reason
Drugs must be effective & safe

One enantiomer caused sedation which was the desired effect, while the other enantiomer caused devastating birth defects known as Phocomelia. Solution was to remove the undesired enantiomer by a validated purification process assured by Assay Validation. Again, GMP deficiency by not having adequate QA and QC programmes which could have answered assay validation. This led to guidelines on the development of New Stereoisomeric Drugs (1992) US FDA.
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

History of GMP
1955 - Polio Vaccine (Cutter Labs, USA)
(Lambert, E.C., Medical Mistakes, Indiana University Press, 1978)

51 Children paralysed 10 Deaths Several possible reasons:

Batch release

Inconsistent viral inactivation process. Quick scale-up production without proper validation of inactivation step. Active live virus production process used heat inactivation step. For virus; scale-up of heat inactivation step may not have been sufficient.
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

History of GMP
PIC-GMP EC-GMP FDA-cGMP FDA-Aseptic Processing FDA-GMP GMP Enforcement by German National Law

WH0-GMP

1968

1971

1978

1983

1985

1987

1989
WHO

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

SEARO

History of GMP
Revision to Annex 1 EC-GMP
WHO-Revised GMP WHO-GMP for Biological products PIC-Adapts GMP According to EC-GMP WHO-GMP for Sterile pharmaceuticals WHO-Guide for Inspection

WHO-Revised GMP

1992

1992

1992

1996

1997

2002

2003
WHO

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

SEARO

What is GMP?
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

More Paper More Work More Cost More Headache

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Quality Management
Determines and implements the quality policy The basic elements are: an appropriate infrastructure or quality system encompassing the Procedures, Processes, and Resources the systematic actions necessary to ensure adequate confidence that a product (or service) will satisfy given requirements for Quality The totality of these actions is termed Quality Assurance
WHO

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

SEARO

Quality management is defined as the aspect of management function that determines and implements the quality policy. The quality policy is a statement by the top management of the company of its overall intentions and direction relating to quality, formally expressed as a corporate policy.

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Quality Management
Terminology may differ Quality System is said to be rarely used in drug manufacturing
The concepts of QA, GMP and Quality Control are interrelated aspects of Quality Management. They are described on the following slides in order to emphasize their relationship and their fundamental importance to the production and control of pharmaceutical products
WHO

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

SEARO

There are two basic elements of this aspect of the management function of a pharmaceutical company:
A working infrastructure = quality system. This includes:
Organizational structure Procedures Processes Resources

Systematic actions to bring the quality policy to life. The totality of these actions is termed quality assurance (QA).

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Quality Relationships
Quality Objective Quality Manual Sampling Specifications Testing Personnel Training Validation Self inspection

Quality Control

Management Aspect Quality system Quality Policy

GMP

Quality Assurance

Quality Management
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Principles of Quality Assurance


Wide-ranging concept
covers all matters that individually or collectively influence the quality of a product

Totality of the arrangements


to ensure that the drug is of the right quality for the intended use

Quality Assurance incorporates GMP


and also product design and development
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Principles of Quality Assurance


Inside an organization, QA is a management tool. In contractual situations, it provides confidence in the supplier.

QA is not the duty of one organizational unit in the company alone, but is the responsibility of all staff members who in any way can influence product quality.

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Requirements for QA Systems I 1. 2. 3. 4. Ensure products are developed correctly Identify managerial responsibilities Provide SOPs for production and control Organize supply and use of correct starting materials 5. Define controls for all stages of manufacture and packaging
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Requirements for QA Systems II

6. Ensure finished product correctly processed and checked before release 7. Ensure products are released after review by authorized person 8. Provide storage and distribution 9. Organize self-inspection
WHO

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

SEARO

GMP
Ensure that products are consistently produced and controlled Diminishes risks that cannot be controlled by testing of product
Cross-contamination Mix-ups

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

What is Good Manufacturing Practices (GMP)?

World Health Organization defines GMP as:

that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Quality Standards
DRA

WHO GMP National GMP

NRA

NCL

Pharmacopeias

Inspection
Marketing Authorization
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Basic Requirements for GMP I


1. 2. 3. 4. 5. Clearly defined and systematically reviewed processes Critical steps validated Appropriate resources: personnel, buildings, equipment, materials Clearly written procedures Trained operators
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Basic Requirements for GMP II


6. 7. 8. 9. Complete records, failure investigations Proper storage and distribution Recall system Complaint handling

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

What aspects of manufacturing does GMP cover?

Equipments

Complaints and Recalls Contract production and analysis Defined Processes

Materials and Storage Written Procedures and Records

Laboratories and Validated Tests

Premises

Validated Processes

Trained Personnel and Hygiene

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Quality Control (QC) Department

Each holder of a manufacturing authorization should have a QC Department Independence from production and other departments is considered to be fundamental Under the authority of an appropriately qualified and experienced person with one or several control laboratories at his or her disposal.

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Basic Requirements for Quality Control

Resources
Adequate facilities Trained personnel Approved procedures

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Basic Requirements for Quality Control

Tasks
Sampling Inspecting Testing Monitoring Releasing/rejecting
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Basic Requirements for Quality Control - I

Objects
Starting materials Packaging materials Intermediates Bulk products Finished products Environmental conditions
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Basic Requirements for Quality Control II


1. 2. 3. 4. Sampling approved by QC department Validated test methods Records Review and evaluation of production documentation 5. Failure investigations for all deviations 6. Ingredients comply with the marketing authorization
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Basic Requirements for Quality Control III 7. 8. 9. 10. Ingredients are of the required purity Proper containers Correct labelling Release of batches by the authorized person 11. Retained samples of starting materials and products
WHO

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

SEARO

Other Duties of the Quality Control Department


1. 2. 3. 4. 5. 6. Establish QC procedures Reference standards Correct labelling Stability testing Complaint investigations Environmental monitoring

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Assessment of Finished Products


Should embrace all relevant factors. For example: production conditions in-process test results manufacturing documentation compliance with finished product specification examination of the finished pack

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Other Issues
GLP GEP GCP GSP GDP

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

Case study

List the most important barriers or Inhibitors against to Implement GMP

WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003

WHO

SEARO

S-ar putea să vă placă și